TY - JOUR
T1 - Male breast cancer
T2 - Is the scenario changing
AU - Contractor, Kaiyumars B.
AU - Kaur, Kanchan
AU - Rodrigues, Gabriel S.
AU - Kulkarni, Dhananjay M.
AU - Singhal, Hemant
PY - 2008/6/16
Y1 - 2008/6/16
N2 - Background: The overall incidence of male breast cancer is around 1% of all breast cancers and is on the rise. In this review we aim to present various aspects of male breast cancer with particular emphasis on incidence, risk factors, patho-physiology, treatment, prognostic factors, and outcome. Methods: Information on all aspects of male breast cancer was gathered from available relevant literature on male breast cancer from the MEDLINE database over the past 32 years from 1975 to 2007. Various reported studies were scrutinized for emerging evidence. Incidence data were also obtained from the IARC, Cancer Mondial database. Conclusion: There is a scenario of rising incidence, particularly in urban US, Canada and UK. Even though more data on risk factors is emerging about this disease, more multi-institutional efforts to pool data with large randomized trials to show treatment and survival benefits are needed to support the existing vast emerging knowledge about the disease.
AB - Background: The overall incidence of male breast cancer is around 1% of all breast cancers and is on the rise. In this review we aim to present various aspects of male breast cancer with particular emphasis on incidence, risk factors, patho-physiology, treatment, prognostic factors, and outcome. Methods: Information on all aspects of male breast cancer was gathered from available relevant literature on male breast cancer from the MEDLINE database over the past 32 years from 1975 to 2007. Various reported studies were scrutinized for emerging evidence. Incidence data were also obtained from the IARC, Cancer Mondial database. Conclusion: There is a scenario of rising incidence, particularly in urban US, Canada and UK. Even though more data on risk factors is emerging about this disease, more multi-institutional efforts to pool data with large randomized trials to show treatment and survival benefits are needed to support the existing vast emerging knowledge about the disease.
UR - http://www.scopus.com/inward/record.url?scp=46749148403&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=46749148403&partnerID=8YFLogxK
U2 - 10.1186/1477-7819-6-58
DO - 10.1186/1477-7819-6-58
M3 - Review article
C2 - 18558006
AN - SCOPUS:46749148403
SN - 1477-7819
VL - 6
JO - World Journal of Surgical Oncology
JF - World Journal of Surgical Oncology
M1 - 58
ER -